In less than 36 hours between the evening of Jan. 12 and the morning of Jan. 14, three local life science companies raised a ...

Sam Altman, the CEO of OpenAI, is backing a groundbreaking initiative aimed at extending human lifespan by a decade through ...

Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT ...

On December 17, 2024, the Competition Tribunal (the Tribunal) issued reasons for its decision to dismiss an application for leave to bring a ...

The Trump administration is bringing new instability to a sector already grappling with a shaky market as well as threats ...

AI, biotech and affordable clean energy will be the focus of an EU drive to make the bloc globally competitive and ensure it ...

The former venture capital arm of Binance will become the family office of CZ and Binance co-founder Yi He, Bloomberg reported.

Binance Labs has been rebranded to YZi Labs to reflect its autonomy and expanded investment focus which now includes Web3, artificial ...

Scientists led by a Macquarie University team have completed construction of the final chromosome in the worlds’ first synthetic yeast genome following more than a decade of work, opening new ...

Researchers believe the innovative idea holds immense promise for tackling a wide range of diseases including cancer through ...

Biotech startup Exsure has raised Rs 3 crore in a funding round led by Unicorn India Ventures to advance its exosomal drug-delivery platform for anti-cancer treatments. The funds will support Exsure's ...